Bengaluru, May 24 -- HealthCare Global Enterprises Ltd. (HCG), India's leading speciality healthcare provider focused on oncology and fertility, announced its unaudited financial results for the quarter and full year ended March 31, 2025. The company reported consolidated revenue of Rs 5,851 million for Q4 FY25, marking an 18% year-on-year growth from Rs 4,946 million in the corresponding quarter last year. For the full financial year 2025, HCG's revenue stood at Rs 22,228 million, reflecting a robust 16% growth over the previous year. EBITDA for Q4 FY25 was recorded at Rs 1,070 million, registering a 14% increase year-on-year, with margins at 18.3%. Profit After Tax (PAT) for the quarter was INR 74 million, down from Rs 213 million in Q4 F...